Child immunization Not Applicable Child immunization
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Study clusters are immunisation microplan areas located in a selected block of Hardoi district, UP. Immunisation microplan areas have defined geographic boundaries and a population of approximately 1000 inhabitants; these catchment areas constitute the basis for immunisation session planning (Village Health and Nutrition Days). A sample of immunization microplanning areas will be identified in each block. 2. In selected areas, we will recruit all frontline workers (ANM, ASHA, AWW) involved in delivery of Village Health and Nutrition Days and associated immunization services. 3.In selected areas, we will recruit all families and primary caregivers (usually mothers) of children 0 to 23 months of age
Exclusion criteria
Exclusion criteria: 1. The study will exclude villages of more than 4000 inhabitants. 2. There are no exclusion criteria for health workers 3. We will exclude caregivers of children not able to understand and speak Hindi or Urdu
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 18/11/2020: 1. Average time to vaccinate per beneficiary (for health workers) defined as the total time spent by frontline workers in each vaccination-related activity for the Village Health and Nutrition Day (VHND) (including activities undertaken during the observed immunisation session and the non-observed activities pre- and post-session), divided by the number of beneficiaries (children 0-23 months of age vaccinated at that session). The total time spent by frontline workers will be the sum of the time spent by the ANM and the ASHA worker. The variable will be measured through non-participant observation of the immunisation session by field staff using a structured questionnaire. Each immunisation session takes place on a single day and lasts for approximately 6 hours. Each ANM will be observed 3 times in the 4-month pre-intervention period and 3 times in the 4-month post-intervention period 2. Immunization dropout from receipt of the first dose to the third dose of pentavalent vaccine (among children eligible for vaccination). Child vaccination status will be measured through a household survey questionnaire. During the household survey, vaccination data will be taken from the immunisation card, or, in the absence of the card, by caregiver report. Each household will be surveyed only once, either in the 4-month pre-intervention period, or the 4-month post-intervention period _____ Previous primary outcome measure: 1. Average time to vaccinate per beneficiary (for health workers) defined as the total time spent by frontline workers in each vaccination-related activity for the Village Health and Nutrition Day (VHND) (including activities undertaken during the observed immunisation session and the non-observed activities pre- and post-session), divided by the number of beneficiaries (children 0-23 months of age vaccinated at that session). The | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 17/11/2020: 1. Process outcomes including intervention fidelity, health worker acceptability, uptake and satisfaction, beneficiary acceptability, uptake, satisfaction, trust , and quality of care will be collected using quantitative methods (non-participant observation, structured questionnaires, linkage to administrative data) and qualitative methods (key informant interviews and focus groups with government officials, health workers, beneficiaries, and field staff; community meetings). Quantitative measures will be collected continuously over the entire study period (encompassing the 4-month pre-intervention period, 2-month intervention introduction period, and the 4-month observation period). Qualitative interviews will be conducted at study end line 2. Missed opportunities for vaccination (MOV), defined as any contact with health services by an individual (child or person of any age) who is eligible for vaccination (e.g. unvaccinated or partially vaccinated and free from any contraindications to vaccination), but does not result in the person receiving one or more of the vaccine doses for which he or she is eligible. Data will be collected continuously over the entire study period (encompassing the 4-month pre-intervention period, 2-month intervention introduction period, and the 4-month observation period) 3. Measures of data quality [including agreement (overall, PPA positive percent agreement; NPA negative percent agreement), sensitivity, specificity, positive and negative predictive value, and coverage percentage point difference when subtracting the MCP vaccination record from a source designated as the reference standard] will compare household survey and administrative data. Data will be collected continuously over the entire study period (encompassing the 4-month pre-intervention period, 2-month intervention introduction period, and the 4-month obser | — |
Countries
India